Position in LGND
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$17,977,284
-$4,580,468 QoQ
Shares Held
90,044
-24.5% QoQ
Ownership
0.449%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. LGND ranks #35 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in LGND
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,977,284 | 90,044 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $22,557,752 | 119,309 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $33,611,960 | 189,748 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $26,058,866 | 229,230 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $22,735,578 | 216,241 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,939,833 | 176,760 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $24,949,333 | 249,269 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $22,762,248 | 270,143 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $20,581,742 | 281,556 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $20,741,652 | 290,418 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $19,182,128 | 320,129 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $28,032,479 | 388,800 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $20,722,366 | 281,707 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $20,639,796 | 308,979 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $23,762,640 | 442,359 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $23,854,226 | 428,585 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $23,508,734 | 335,003 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $34,926,352 | 362,469 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $31,128,575 | 358,162 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,208,829 | 405,776 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $16,593,744 | 174,482 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $22,897,746 | 369,081 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $11,713,833 | 196,992 | Shares | Defined | 2020-10-21 | |
| No filing history on record for this holder in this stock. | ||||||